Halil Türkan

Halil Türkan

Auto-generated profile, based on publicly available information

Halil Türkan

Sanliurfa Mehmet Akif Inan Training and Research Hospital, Mehmetcik mah. 7058. Sok. No:4c D:20 Karakopru, Sanliurfa, Turkey.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2016 in Journal of Breast Health
Verified
Journal Article
Closed access
HTHalil Turkan
Halil Turkan
MGM. Sehsuvar Gokgoz
M. Sehsuvar Gokgoz
ITIsmet Tasdelen
Ismet Tasdelen
HDHalit Ziya Dundar
Halit Ziya Dundar
Gestational gigantomastia is a rare condition characterized by fast, disproportionate and excessive breast growth, decreased quality of life in pregnancy, and presence of psychologic as well as physical complications. The etiology is not fully understood, although hormonal changes in pregnancy are considered responsible. Prolactin is the most important hormone. To date, 125 cases of gigantomastia have been reported in the literature. In this case presentation, we report a pregnant woman aged 26 years with a 22-week gestational age with gestational gigantomastia and review the diagnosis and treatment of this rare disease in relation with the literature.

13 June 2025 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
PDF file
GCGökhan Coşkun
Gökhan Coşkun
UKUfuk Karabacak
Ufuk Karabacak
HTHalil Türkan
Halil Türkan
MMMurat Can Mollaoğlu
Murat Can Mollaoğlu
MBMeriç Emre Bostancı
Meriç Emre Bostancı
KKKürşat Karadayı
Kürşat Karadayı
Purpose: Sarcopenia has been identified as a prognostic factor in various cancers. The aim of the study is to investigate the role of sarcopenia in the development of early complications following Primary Cytoreductive Surgery in advanced stage ovarian cancer patients. Methods: A total of 57 patients who underwent Cytoreductive Surgery due to advanced stage ovarian cancer at the Surgical Oncology Clinic of…………. University Hospital between January 2013 and June 2021 were retrospectively analyzed. Routine preoperative Computed Tomography(CT) images were used to measure the cross-sectional areas of the paraspinal muscles, abdominal wall muscles at the L3 level in cm2. The Skeletal Muscle Index (SMI) and Psoas Muscle Index (PMI) values were calculated. Postoperative early complications were classified as Clavien-Dindo grade 3 and above major complications. Results: Based on SMI measurements, 23 patients with SMI < 38.5 were classified as sarcopenic, while 34 patients with SMI ≥ 38.5 were classified as nonsarcopenic; based on PMI measurements, 19 patients with PMI < 4.3 were classified as sarcopenic, while 38 patients with PMI ≥ 4.3 were classified as nonsarcopenic. Major complications occurring in the early postoperative period were significantly more common in the sarcopenic group. High Peritoneal Carcinomatosis Index (PCI) score and FIGO 3 C stage were associated with a significantly higher incidence of early complications. High PCI score and SMI < 38.5 value were identified as risk factors for postoperative early complications. Conclusions: The quantitative measurements of sarcopenia using routine CT imaging for preoperative staging are a useful and cost-effective method. Determining the sarcopenic status of patients before treatment offers an advantage in predicting treatment complications.

1 April 2021 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
YAYuksel Altinel
Yuksel Altinel
ETErsoy Taşpinar
Ersoy Taşpinar
HTHalil Türkan
Halil Türkan
FAFuat Aksoy
Fuat Aksoy
YÖYılmaz Özen
Yılmaz Özen
RARıdvan Ali̇
Rıdvan Ali̇
Mevcut çalışma kapsamında, İdiyopatik Trombositopenik Purpuralı (İTP) hastalarında yapılan splenektominin uzun sonuçlarını belirleyerek literatür eşliğinde tartışmak amaçlanmıştır. 2008 ve 2017 yılları arasında Kronik ITP nedeniyle splenektomi yapılan 300 hasta, retrospektif olarak çalışmaya dahil edildi. Veriler, hastaların tıbbi kayıtlarından ve ameliyat notlarından elde edildi. Hastalar, cinsiyet, başvuru anındaki şikayet, majör kanama durumu, trombosit sayıları ve diğer hematolojik parametreler, ilk basamak tedavi kombinasyonları, splenektomi prosedürleri (açık veya laparoskopik), postoperatif trombosit sayıları ve splenektomi ile ilgili olarak, splenektomi sonrası erken ve geç dönem sonuçları, rekürrens, mortalite ve morbidite, splenektomi sonrası üçüncü basamak tedavi ihtiyacı açısından değerlendirildi. Kronik ITP nedeniyle splenektomi yapılan 306 hastanın 6’sı veri eksikliği nedeniyle çalışma dışı bırakıldı. Verisine ulaşılan 300 hasta (88 erkek ve 212 kadın) çalışmaya dahil edildi. 254 (% 84,6) hastada tam yanıt, 2 (% 4) hastada yanıt vardı ve 46 (% 15,3) hastada ise yanıtsızlık vardı. ITP'nin iki yıldaki rekürrens oranı 44 (% 14.6) idi. İTP hem medikal hem de cerrahi tedavilerin uygulanabilirliği açısından en çok görülen hematolojik hastalıklardan biridir ve günümüz tedavi algoritmasında ilk seçenek steroid olarak bilinmektedir. Medikal tedaviye yanıt alınamayan, ilaç yan etkisi gelişen veya yüksek doz steroid ihtiyacı olan hastalarda ise splenektomi halen önemli bir tedavi seçeneği olarak görünmektedir.

20 March 2019 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
PTPınar Taşar
Pınar Taşar
HTHalil Türkan
Halil Türkan
ZGZehra Gezer
Zehra Gezer
DKDemet Kerimoğlu
Demet Kerimoğlu
AKAdife Koç
Adife Koç
SKSadık Kılıçturgay
Sadık Kılıçturgay
Objective: Enteral nutrition (EN) is safe, well tolerated and efficient nutritional support for patients with functional gastrointestinal (GI) tract. The major problems of EN are intolerance of the nutrition products and problems of achieving the targeted dose. This is a prospective observational study investigating the nutrition related problems, solutions to those problems, and the time for achieving the targeted dose in patients who received EN in our inpatient clinic and intensive care unit. Methods: This prospective study was made between 11/01/2015-11/01/2016. This study evaluated patients demographic findings, nutrition status, daily calculated calories (25 kcal/kg/day), daily calculated protein dose (1.5 gr/kg/day), daily delivered calories, daily delivered protein dose, whether or not additional parenteral nutrition applied, biochemical parameters (blood sugar, Na, K, Ca, Mg, cholesterol, liver function tests, urea, CRP, albumin, prealbumin), intolerance issues, complications and EN termination reasons. Results: Considering 2258 patients hospitalized during this period, a total of 70 patients (3.1%) were applied EN (Female/Male: 30/40, The mean age of the patients was 60±16.5 years). The average application time is 11.5 (2-42) days. Among these patients, 26 had an NRS-2002 score ≥3, and only 6 had a BMI<18.8. The rate of calorie and protein application was lower than the calculated, respectively, 37.14% and 52.8% of the cases. It was observed that 40.54% of total malignant patients were subjected to immunonutrition. There were GI tract related problems in 20 patients. Diarrhea was the most important problem during enteral support. Oral supplementation intolerance problem was observed in 20% of the population. Hyperglycemia was detected in 35.7% of the patients, and more than half of them were between 200-300 mg/dL levels. Almost 53% of the patients had malignancy, however, only 5 of them had prescription for oral supplementation during discharge. Conclusion: EN was performed less than required with inaccurate calories and protein intake, and immunonutrition protocols in malignant patients are not properly complied and oral supplement prescription for those patients is rarely given after hospital discharge. Additionally, product intolerance is seriously frequent, and product and dosage changes should be done more actively.

18 June 2025 in Indian Journal of Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
HTHalil Turkan
Halil Turkan
UKUfuk Karabacak
Ufuk Karabacak
GCGökhan Coskun
Gökhan Coskun
ZHZekiye Hasbek
Zekiye Hasbek
KKKürşat Karadayı
Kürşat Karadayı